Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1429, 2004-01, pp. : 17-17
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Wild-type KRAS state boosts response in colorectal cancer
Inpharma, Vol. 1, Iss. 1647, 2008-01 ,pp. :
Access to resources
Recommend
Fluorouracil plus eniluracil maintains QOL in colorectal cancer
Inpharma, Vol. 1, Iss. 1373, 2003-01 ,pp. :
Capecitabine equivalent to IV fluorouracil in colorectal cancer
Inpharma, Vol. 1, Iss. 1316, 2001-01 ,pp. :
Fluorouracil plus eniluracil maintains QOL in colorectal cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 398, 2003-01 ,pp. :
Pharmacogenomics of 5-Fluorouracil/Oxaliplatin in Colorectal Cancer
Current Pharmacogenomics, Vol. 4, Iss. 4, 2006-12 ,pp. :